Oncology Pharma Inc.
ONPH · OTC
3/31/2022 | 3/31/2021 | 3/31/2020 | 3/31/2019 | |
|---|---|---|---|---|
| Market Cap | $113,038 | $297,049 | $3,361 | $3,012 |
| - Cash | $4 | $9 | $2 | $7 |
| + Debt | $662 | $238 | $129 | $238 |
| Enterprise Value | $113,696 | $297,278 | $3,489 | $3,243 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$1 | -$1 | -$1 |
| % Margin | – | – | – | – |
| EBITDA | $229 | -$14,660 | -$181 | -$818 |
| % Margin | – | – | – | – |
| Net Income | -$104,627 | -$97,473 | -$208 | -$850 |
| % Margin | – | – | – | – |
| EPS Diluted | -3.42 | -6.76 | -0.12 | -0.72 |
| % Growth | 49.4% | -5,533.3% | 83.3% | – |
| Operating Cash Flow | $369 | -$117 | -$22 | -$37 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | $369 | -$117 | -$22 | -$37 |